Archives
-
RESTRICT-seq Maps KAT6A-Linked SCC Resistance
2026-09-04
The RESTRICT-seq preprint introduces a time-gated CRISPR screening strategy for separating epigenetic dependencies associated with the establishment and maintenance of squamous cell carcinoma resistance. Its identification of KAT6A as a resistance-linked vulnerability connects temporal functional genomics with oncogene-induced senescence and provides a rationale for pharmacological validation in cancer biology research.
-
Pemetrexed as a Mechanistic Assay Probe
2026-09-04
Pemetrexed is more than a cytotoxic readout: it is a mechanistic probe for folate-dependent nucleotide stress in tumor models. This article shows how to pair pemetrexed response profiling with DNA-repair phenotyping, using malignant mesothelioma research as a practical example.
-
Ciprofloxacin Workflows for Resistance Research
2026-09-03
Ciprofloxacin is more than a routine susceptibility control: it is a mechanistic probe for DNA replication inhibition and a practical comparator in plasmid-mediated resistance studies. This guide translates recent CREC transmission findings into solvent-aware assay workflows, controls, and troubleshooting decisions for antimicrobial resistance research.
-
NF449 Reveals a Platelet P2X1 Antithrombotic Axis
2026-09-03
The reference study established NF449 as a pharmacological tool for separating platelet P2X1 signaling from P2Y1- and P2Y12-mediated responses. Its dose-dependent inhibition of platelet activation and experimental thrombosis, with no significant bleeding-time prolongation at a selective dose, provides a mechanistic framework for platelet aggregation inhibition research while highlighting important selectivity limits.
-
DNA Damage Biomarkers Sharpen Micronucleus Testing
2026-09-02
Avlasevich and colleagues combined flow-cytometric micronucleus scoring with DNA damage response biomarkers to distinguish bona fide genotoxicity from biologically irrelevant positive results. Their findings show that requiring concordant biomarker responses can substantially improve assay specificity while preserving sensitivity, and that benchmark-dose visualization helps interpret genotoxic mode of action and potency.
-
VX-661 and the Proteostasis Logic of CFTR Rescue
2026-09-02
VX-661 is more than a F508del CFTR corrector: it is a practical tool for testing how folding, trafficking, calnexin-dependent proteostasis, and channel activation interact. This translational perspective outlines an assay strategy that separates surface rescue from CFTR-mediated chloride channel activity and supports more precise variant-response mapping.
-
Isochlorogenic acid A: From Molecule to Model
2026-09-01
Isochlorogenic acid A research spans solvent-aware small-molecule assays and engineered wound-repair systems. This guide explains how 3,5-Dicaffeoylquinic acid formulation, controls, and biological endpoints should be interpreted together.
-
Dextrose in Hypoxia and Immunometabolism
2026-09-01
Learn how to use Dextrose (D-glucose) as a controlled nutrient variable in hypoxia, tumor–immune co-culture, and cellular energy production assays. This workflow combines practical preparation guidance, factorial experimental design, and troubleshooting for more reproducible glucose metabolism research.
-
Carbapenemase Gene Transmission in CREC
2026-08-31
A 2025 BMC Microbiology study integrated resistance-gene localization, plasmid-transfer testing, mobile-element profiling, and strain typing to characterize carbapenem-resistant Enterobacter cloacae across eight teaching hospitals in Guangdong. Its findings identify plasmid-associated blaNDM-1 and efficient horizontal dissemination as major concerns for antimicrobial resistance research, while also showing substantial multidrug resistance among carbapenemase-gene-positive isolates.
-
γH2AX DNA Damage Detection Kit Workflow
2026-08-31
Turn radiation, drug, and genotoxicity experiments into spatially resolved DNA double-strand break measurements with a red γ-H2AX immunofluorescence workflow. The assay connects radiosensitizer screening, apoptosis studies, and DNA repair research while providing practical controls, quantitative readouts, and troubleshooting guidance.
-
Ferrostatin-1: Practical Ferroptosis Assay Guide
2026-08-30
Ferrostatin-1 (Fer-1) turns ferroptosis from a suspected endpoint into a testable causal mechanism by rescuing cells from lipid-peroxidation-driven injury. This workflow shows how to pair Fer-1 with RSL3 or erastin, redox readouts, and NF-κB/PTGS2 analysis in melanocyte, cancer, and neurodegeneration studies.
-
MRTFA–KCNMB1 Control of Cancer Cell Stiffness
2026-08-29
The reference study identifies potassium efflux and the BK-channel auxiliary subunit KCNMB1 as regulators of cancer-cell stiffness downstream of MRTFA. By combining mechanical, electrophysiological, immune-cytotoxicity, transcriptomic, and mouse-model approaches, it shows that BK-channel activation can stiffen cancer cells, improve lymphocyte-mediated killing, and reduce metastatic colonization.
-
EGCG Nanoparticles Enhance FLASH Radiotherapy
2026-08-28
Xu and colleagues developed functionalized self-assembled EGCG nanoparticles, termed BENPs, to increase tumor sensitivity to FLASH-RT while preserving the modality’s normal-tissue rationale. In a 4T1-based study, BENPs enhanced radiation-associated ROS and DNA damage, promoted tumor-cell death, and stimulated antitumor immune features, although further validation is needed before clinical translation.
-
Kir4.1–Panx3 Signaling in Orofacial Neuropathic Pain
2026-08-28
Feng et al. identify a trigeminal ganglion Kir4.1–Panx3 signaling axis in chronic constriction injury of the infraorbital nerve, linking satellite glial potassium-channel loss with reactive oxygen species and p38 MAPK activity. Genetic knockdown, overexpression, cellular experiments, and rescue studies support Panx3 as a downstream mediator of orofacial mechanical allodynia, while also revealing context-dependent signaling behavior that warrants further validation.
-
Nile Red Workflows for Lipid Droplet Analysis
2026-08-27
Nile Red enables practical intracellular lipid droplet staining with a dual-channel strategy that separates droplet-selective green fluorescence from broader red lipid-associated signal. This guide translates findings from an autophagy–lipid accumulation study into assay design, imaging, quantitative analysis, and troubleshooting workflows.